TY - CHAP
T1 - The economics of patents and innovation in pharma
AU - Canoy, Marcel
AU - Versteegh, Matthijs
PY - 2022
Y1 - 2022
N2 - This chapter provides an overview of the economics of competition in the pharmaceutical sector. It starts with the basics: the financing of innovation through the patent system, its rationale, practice and a short discussion of alternative financing models. The chapter then discusses the relationship between competition and the negotiation of prices, its rationale, underlying principles, bargaining theory and the potential problems associated with current practices. The chapter concludes with suggestions for improving competition while retaining the incentives for innovation.
AB - This chapter provides an overview of the economics of competition in the pharmaceutical sector. It starts with the basics: the financing of innovation through the patent system, its rationale, practice and a short discussion of alternative financing models. The chapter then discusses the relationship between competition and the negotiation of prices, its rationale, underlying principles, bargaining theory and the potential problems associated with current practices. The chapter concludes with suggestions for improving competition while retaining the incentives for innovation.
UR - http://www.scopus.com/inward/record.url?scp=85160900290&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85160900290&partnerID=8YFLogxK
UR - https://www.e-elgar.com/shop/gbp/eu-competition-law-and-pharmaceuticals-9781802204407.html
U2 - 10.4337/9781802204414.00010
DO - 10.4337/9781802204414.00010
M3 - Chapter
AN - SCOPUS:85160900290
SN - 9781802204407
T3 - New Horizons in Competition Law and Economics series
SP - 48
EP - 59
BT - EU Competition Law and Pharmaceuticals
A2 - Sauter, Wolf
A2 - Canoy, Marcel
A2 - Mulder, Jotte
PB - Edward Elgar Publishing Ltd.
ER -